Wound care surfactant sales will expand through 2036, with PHMB holding 42.7% of the product segment in 2026. The market was valued at USD 728.02 million in 2025 and is expected to be worth USD 1132.66 million by 2036, creating an incremental opportunity of USD 374.80 million between 2026 and 2036.